Surveillance de la consommation des antibiotiques-Réseau ATB Raisin-Résultats 2012 / 2014 / Maladies infectieuses / Rapports et synthèses / Publications et outils / Accueil, ANNEXE, vol.3, 2016. ,
, le rapport d'analyse de l'année 2013-CommuniquéANSM : Agence nationale de sécurité du médicament et des produits de santé, 2016.
, BEH n°12-13/2013 / 2013 / Archives / BEH-Bulletin épidémiologique hebdomadaire / Publications et outils / Accueil [Internet, 2016.
, Epidemiological trends in invasive aspergillosis in France: the SAIF network, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00680990
, Clin Microbiol Infect, vol.17, issue.12, pp.1882-1891, 2011.
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry, Clin Infect Dis, vol.48, issue.3, pp.265-73, 2009. ,
, WHO | Antimicrobial resistance: global report on surveillance, 2014.
Impact des antifongiques sur la résistance des principales espèces de Candida en réanimationEvolution et tendances sur 10 ans, Journal de Mycologie Médicale / Journal of Medical Mycology, vol.26, issue.2, p.6, 2016. ,
Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? Clin Infect Dis, p.885, 2015. ,
Adherence to recommendations for the use of antifungal agents in a tertiary care hospital, J Antimicrob Chemother, vol.67, issue.10, pp.2506-2519, 2012. ,
Revue de pertinence des prescriptions des nouveaux antifongiques systémiques dans un hôpital universitaire. Médecine et Maladies Infectieuses, vol.37, pp.223-231, 2007. ,
, , 2016.
Invasive Aspergillosis Surveillance Network of the Assistance Publique-Hôpitaux de Paris. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area, J Hosp Infect, vol.51, issue.4, pp.288-96, 2002. ,
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery, JCO, vol.15, issue.1, pp.139-186, 1997. ,
, Critères d'infections fongiques invasives, 2016.
, Conférence de consensus SFHH de mars, 2000.
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia, New England Journal of Medicine, vol.356, issue.4, pp.348-59, 2007. ,
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 update, Bone Marrow Transplant, vol.46, issue.5, pp.709-727, 2011. ,
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis, New England Journal of Medicine, vol.347, issue.6, pp.408-423, 2002. ,
European Confederation of Medical Mycology, 2015. ,
Preliminary animal pharmacokinetics of the parenteral antifungal agent, vol.872 ,
, Antimicrob Agents Chemother, vol.41, issue.11, pp.2339-2383, 1997.
Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma, Antimicrob Agents Chemother, vol.48, issue.3, pp.815-838, 2004. ,
Combination of Voriconazole and Anidulafungin for Treatment of Triazole-Resistant Aspergillus fumigatus in an In Vitro Model of Invasive Pulmonary Aspergillosis, Antimicrob Agents Chemother, vol.56, issue.10, pp.5180-5185, 2012. ,
Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts, J Clin Microbiol, vol.36, issue.10, pp.2950-2956, 1998. ,
In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp, Antimicrob Agents Chemother, vol.42, issue.10, pp.2726-2756, 1998. ,
British Society for Medical Mycology. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections, Lancet Infect Dis, vol.3, issue.4, pp.230-270, 2003. ,
Revue de pertinence sur le bon usage des antifongiques à l'échelle d'une région française, 2013. ,
Audit clinique des prescriptions d'antifongiques systémiques couteux au centre hospitalier universitaire de Besançon. Médecine et Maladies Infectieuses, vol.39, pp.125-157, 2009. ,
Acceptance of Pharmacist-Driven Antimicrobial Stewardship Recommendations With Differing Levels of Physician Involvement in a Children's Hospital. Clin Pediatr (Phila), 2016. ,
Clinical Pharmacist Management of Bacteremia in a Community Hospital Emergency Department, Ann Pharmacother, 2017. ,
Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia, JCO, vol.19, issue.1, pp.253-262, 2001. ,
Tissue Penetration of Antifungal Agents, Clin Microbiol Rev, vol.27, issue.1, pp.68-88, 2014. ,
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes, Clin Infect Dis, vol.46, issue.2, pp.201-212, 2008. ,
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections, Clin Infect Dis, vol.55, issue.3, pp.381-90, 2012. ,
Niveau de preuve du suivi thérapeutique pharmacologique du voriconazole, Therapie, vol.66, issue.2, pp.109-123, 2011. ,
Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization, Annales de Biologie Clinique, vol.72, issue.4, pp.391-404, 2014. ,
Effect of omeprazole on the steady-state pharmacokinetics of voriconazole, Br J Clin Pharmacol, vol.56, issue.1, pp.56-61, 2003. ,
Subtherapeutic voriconazole concentrations associated with concomitant dexamethasone: case report and review of the literature, J Clin Pharm Ther, vol.41, issue.4, pp.441-444, 2016. ,
,
Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed, J Antimicrob Chemother, vol.69, issue.7, pp.1993-2002, 2014. ,
Antifungal stewardship: Implementation in a French teaching hospital. Médecine et Maladies Infectieuses, vol.44, pp.154-162, 2014. ,
, Impact de l'éducation et un programme de gérance antifongique pour candidoses dans un centre de soins tertiaires thaïlandais, 2017.
, Available from: /fr/documents/773c7033dcc91c33d4f1e7d1df31139829a2b78b
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period, Haematologica, vol.91, issue.7, pp.986-995, 1989. ,
Sérologie aspergillaire, d'hier à aujourd'hui pour demain, Journal de Mycologie Médicale / Journal of Medical Mycology, vol.22, issue.1, pp.72-82, 2012. ,
Performances de la PCR Aspergillus sur sérum pour le diagnostic des aspergilloses invasives, Journal de Mycologie Médicale / Journal of Medical Mycology, vol.25, issue.3, p.220, 2015. ,
PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance, J Clin Microbiol, vol.52, issue.10, pp.3731-3773, 2014. ,
Serious fungal infections in Egypt, Eur J Clin Microbiol Infect Dis, 2017. ,
Serious fungal infections in Portugal, Eur J Clin Microbiol Infect Dis, 2017. ,
Serious fungal infections in the Philippines, Eur J Clin Microbiol Infect Dis, 2017. ,
Post-influenza aspergillosis, do not underestimate influenza B. Infect Drug Resist, vol.10, pp.61-68, 2017. ,
Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study, Intensive Care Med, vol.38, issue.11, pp.1761-1769, 2012. ,
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies, Blood, vol.119, issue.8, pp.1831-1837, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00818508
Évaluation de la pertinence des prescriptions d'antifongiques au centre hospitalier universitaire de Grenoble, 2011. ,